Abstract
The synthesis of two new analogs of 2'-deoxyguanosine, 6-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H-pyrrolo[3,2-c] pyridin-4(5H)-one (8) and 6-amino-1-beta-D-arabinofuranosyl-1H-pyrrolo[3,2-c]-pyridin-4(5H)-one (13) has been accomplished by glycosylation of the sodium salt of ethyl 2-cyanomethyl-1H-pyrrole-3-carboxylate (4c) using 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-alpha-D-erythro-pentofuranose( 5) and 1-chloro-2,3,5-tri-O-benzyl-alpha-D-arabinofuranose (9), respectively. The resulting blocked nucleosides, ethyl 2-cyanomethyl-1-(2-deoxy-3,5-di-O-p-toluoyl-beta-D-erythro- pentofuranosyl)-1H-pyrrole-3-carboxylate (6) and ethyl 2-cyanomethyl-1-(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)- 1H-pyrrole-3-carboxylate, were ring closed with hydrazine to form 5-amino-6-hydrazino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1H- pyrrolo[3,2-c]-pyridin-4(5H)-one (7) and 5,6-diamino-1-(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)-1H- pyrrolo[3,2-c]pyridin-4(5H)-one (11), respectively. Treatment of 7 with Raney nickel provided the 2'-deoxyguanosine analog 8 while reaction of 11 with Raney nickel followed by palladium hydroxide/cyclohexene treatment gave the 2'-deoxyguanosine analog 13. The anomeric configuration of 8 was assigned as beta by proton NMR, while that of 13 was confirmed as beta by single-crystal X-ray analysis of the deblocked precursor ethyl 2-cyanomethyl-1-beta-D-arabinofuranosyl-1H-pyrrole-3-carboxylate (10a).
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cottam H. B., Kazimierczuk Z., Geary S., McKernan P. A., Revankar G. R., Robins R. K. Synthesis and biological activity of certain 6-substituted and 2,6-disubstituted 2'-deoxytubercidins prepared via the stereospecific sodium salt glycosylation procedure. J Med Chem. 1985 Oct;28(10):1461–1467. doi: 10.1021/jm00148a015. [DOI] [PubMed] [Google Scholar]
- Preobrazhenskaya M. N., Vigdorchik M. M., Suvorov N. N. Glycosylindoles. VII. Synthesis of 1-(D-beta-ribofuranosyl)indole. Tetrahedron. 1967 Dec;23(12):4653–4660. doi: 10.1016/s0040-4020(01)92563-3. [DOI] [PubMed] [Google Scholar]
- Revankar G. R., Gupta P. K., Adams A. D., Dalley N. K., McKernan P. A., Cook P. D., Canonico P. G., Robins R. K. Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. J Med Chem. 1984 Nov;27(11):1389–1396. doi: 10.1021/jm00377a002. [DOI] [PubMed] [Google Scholar]
- Robins M. J., Robins R. K. Purine nucleosides. XI. The synthesis of 2'-deoxy-9-alpha- and-beta-D-ribofuranosylpurines and the correlation of their anomeric structure with proton magnetic resonance spectra. J Am Chem Soc. 1965 Nov 5;87(21):4934–4940. doi: 10.1021/ja00949a042. [DOI] [PubMed] [Google Scholar]
- Schneller S. W., Hosmane R. S., MacCartney L. B., Hessinger D. A. Synthesis and xanthine oxidase inhibitory analysis of 1H-pyrrolo[3,2-c]pyridine-4,6(5H,7H)-dione (3,7-dideazaxanthine) and two of its derivatives. J Med Chem. 1978 Sep;21(9):990–993. doi: 10.1021/jm00207a028. [DOI] [PubMed] [Google Scholar]
- Walton E., Holly F. W., Jenkins S. R. Indole and 4-aminoindole nucleosides. J Org Chem. 1968 Jan;33(1):192–197. doi: 10.1021/jo01265a602. [DOI] [PubMed] [Google Scholar]
